Welcome to LookChem.com Sign In|Join Free
  • or
Thiazolo[4,5-b]pyridin-2-amine, also known as TAZOPANAM, is a chemical compound with the molecular formula C7H6N4S. It belongs to the class of thiazole compounds, which are well known for their diverse biological activities. Thiazolo[4,5-b]pyridin-2-amine has been studied for its potential pharmacological properties, including its ability to act as an antioxidant, antimicrobial, and anticancer agent. Thiazolo[4,5-b]pyridin-2-amine has also been investigated for its potential application in the development of new drugs and pharmaceuticals. Its unique chemical structure and potential biological activities make thiazolo[4,5-b]pyridin-2-amine an interesting target for further research and development in the field of medicinal chemistry and drug discovery.

13575-41-2

Post Buying Request

13575-41-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13575-41-2 Usage

Uses

Used in Pharmaceutical Industry:
Thiazolo[4,5-b]pyridin-2-amine is used as a potential drug candidate for its pharmacological properties, such as its antioxidant, antimicrobial, and anticancer activities. Its diverse biological activities make it a promising compound for the development of new drugs and pharmaceuticals.
Used in Medicinal Chemistry Research:
Thiazolo[4,5-b]pyridin-2-amine is used as a subject of research in medicinal chemistry to explore its potential applications and to understand its mechanism of action. Its unique chemical structure and biological activities provide valuable insights for the development of novel therapeutic agents.
Used in Drug Discovery:
Thiazolo[4,5-b]pyridin-2-amine is used as a target for drug discovery efforts, as its potential pharmacological properties and diverse biological activities make it a promising candidate for the development of new therapeutic agents. Further research and development in this area could lead to the discovery of innovative drugs with improved efficacy and safety profiles.

Check Digit Verification of cas no

The CAS Registry Mumber 13575-41-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,5,7 and 5 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 13575-41:
(7*1)+(6*3)+(5*5)+(4*7)+(3*5)+(2*4)+(1*1)=102
102 % 10 = 2
So 13575-41-2 is a valid CAS Registry Number.

13575-41-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name [1,3]Thiazolo[4,5-b]pyridin-2-amine

1.2 Other means of identification

Product number -
Other names thiazolo[4,5-b]pyridin-2-ylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13575-41-2 SDS

13575-41-2Synthetic route

2-pyridylthiourea
14294-11-2

2-pyridylthiourea

[1,3]thiazolo[4,5-b]pyridin-2-amine
13575-41-2

[1,3]thiazolo[4,5-b]pyridin-2-amine

Conditions
ConditionsYield
With bromine In chloroform Heating;57%
2-aminopyridine
504-29-0

2-aminopyridine

potassium thioacyanate
333-20-0

potassium thioacyanate

[1,3]thiazolo[4,5-b]pyridin-2-amine
13575-41-2

[1,3]thiazolo[4,5-b]pyridin-2-amine

Conditions
ConditionsYield
With bromine; acetic acid
2-aminopyridine
504-29-0

2-aminopyridine

methyl halide

methyl halide

[1,3]thiazolo[4,5-b]pyridin-2-amine
13575-41-2

[1,3]thiazolo[4,5-b]pyridin-2-amine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 64 percent / aq. HCl / 6 h / Heating
2: 57 percent / Br2 / CHCl3 / Heating
View Scheme
2-Amino-3-bromopyridine
13534-99-1

2-Amino-3-bromopyridine

[1,3]thiazolo[4,5-b]pyridin-2-amine
13575-41-2

[1,3]thiazolo[4,5-b]pyridin-2-amine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: acetone / 14 h / 60 °C
2: sodium hydroxide; water / methanol / 2 h / 70 °C
3: sodium hydride / mineral oil; N,N-dimethyl-formamide / 0.14 h / 90 °C
View Scheme
C13H10BrN3OS

C13H10BrN3OS

[1,3]thiazolo[4,5-b]pyridin-2-amine
13575-41-2

[1,3]thiazolo[4,5-b]pyridin-2-amine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium hydroxide; water / methanol / 2 h / 70 °C
2: sodium hydride / mineral oil; N,N-dimethyl-formamide / 0.14 h / 90 °C
View Scheme
1-(3-bromopyridin-2-yl)thiourea

1-(3-bromopyridin-2-yl)thiourea

[1,3]thiazolo[4,5-b]pyridin-2-amine
13575-41-2

[1,3]thiazolo[4,5-b]pyridin-2-amine

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide; mineral oil at 90℃; for 0.14h;8.6 g
1-hydroxy-pyrrolidine-2,5-dione
6066-82-6

1-hydroxy-pyrrolidine-2,5-dione

[1,3]thiazolo[4,5-b]pyridin-2-amine
13575-41-2

[1,3]thiazolo[4,5-b]pyridin-2-amine

1-{([1,3]thiazolo[4,5-b]pyridin-2-yldiazenyl)oxy}-pyrrolidine-2,5-dione

1-{([1,3]thiazolo[4,5-b]pyridin-2-yldiazenyl)oxy}-pyrrolidine-2,5-dione

Conditions
ConditionsYield
Stage #1: [1,3]thiazolo[4,5-b]pyridin-2-amine With hydrogenchloride; sodium nitrite at 0 - 5℃;
Stage #2: 1-hydroxy-pyrrolidine-2,5-dione With sodium hydroxide at 0 - 5℃; pH=8 - 10;
55%
N-hydroxyphthalimide
524-38-9

N-hydroxyphthalimide

[1,3]thiazolo[4,5-b]pyridin-2-amine
13575-41-2

[1,3]thiazolo[4,5-b]pyridin-2-amine

2-{([1,3]thiazolo[4,5-b]pyridin-2-yldiazenyl)oxy}-1H-isoindole-1,3(2H)-dione

2-{([1,3]thiazolo[4,5-b]pyridin-2-yldiazenyl)oxy}-1H-isoindole-1,3(2H)-dione

Conditions
ConditionsYield
Stage #1: [1,3]thiazolo[4,5-b]pyridin-2-amine With hydrogenchloride; sodium nitrite at 0 - 5℃;
Stage #2: N-hydroxyphthalimide With sodium hydroxide at 0 - 5℃; pH=8 - 10;
52%
1-hydroxy-pyrrolidine-2,5-dione
6066-82-6

1-hydroxy-pyrrolidine-2,5-dione

[1,3]thiazolo[4,5-b]pyridin-2-amine
13575-41-2

[1,3]thiazolo[4,5-b]pyridin-2-amine

1-{[1,3]thiazolo[4,5-b]pyridin-2-yloxy}pyrrolidine-2,5-dione

1-{[1,3]thiazolo[4,5-b]pyridin-2-yloxy}pyrrolidine-2,5-dione

Conditions
ConditionsYield
Stage #1: [1,3]thiazolo[4,5-b]pyridin-2-amine With hydrogenchloride; sodium nitrite at 0 - 5℃;
Stage #2: 1-hydroxy-pyrrolidine-2,5-dione With sodium hydroxide at 0 - 5℃; pH=10 - 12;
51%
[1,3]thiazolo[4,5-b]pyridin-2-amine
13575-41-2

[1,3]thiazolo[4,5-b]pyridin-2-amine

thiazolo(4,5-b)pyridine
273-98-3

thiazolo(4,5-b)pyridine

Conditions
ConditionsYield
With isopentyl nitrite In tetrahydrofuran at 65℃; for 4h;46.6%
N-hydroxyphthalimide
524-38-9

N-hydroxyphthalimide

[1,3]thiazolo[4,5-b]pyridin-2-amine
13575-41-2

[1,3]thiazolo[4,5-b]pyridin-2-amine

2-{[1,3]thiazolo[4,5-b]pyridin-2-yloxy}-1H-isoindole-1,3(2H)-dione

2-{[1,3]thiazolo[4,5-b]pyridin-2-yloxy}-1H-isoindole-1,3(2H)-dione

Conditions
ConditionsYield
Stage #1: [1,3]thiazolo[4,5-b]pyridin-2-amine With hydrogenchloride; sodium nitrite at 0 - 5℃;
Stage #2: N-hydroxyphthalimide With sodium hydroxide at 0 - 5℃; pH=10 - 12;
42%
C35H42N4O4

C35H42N4O4

[1,3]thiazolo[4,5-b]pyridin-2-amine
13575-41-2

[1,3]thiazolo[4,5-b]pyridin-2-amine

3-(5-methyl-1-tricyclo[3.3.1.13,7]decan-1-ylmethyl-1H-pyrazol-4-yl)-6-[8-(thiazolo[4,5-b]pyridin-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-pyridine-2-carboxylic acid tert-butyl ester
1430846-28-8

3-(5-methyl-1-tricyclo[3.3.1.13,7]decan-1-ylmethyl-1H-pyrazol-4-yl)-6-[8-(thiazolo[4,5-b]pyridin-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-pyridine-2-carboxylic acid tert-butyl ester

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃;
di(succinimido) carbonate
74124-79-1

di(succinimido) carbonate

tert-butyl 3-{1-[(3-{[13-(tert-butoxycarbonyl)-2,2,7,7-tetramethyl-10,10-dioxido-3,3-diphenyl-4,9-dioxa-10λ6-thia-13-aza-3-silapentadecan-15-yl]oxy}-5,7-dimethyltricyclo[3.3.1.13'7]dec-1-yl)methyl]-5-methyl-1H-pyrazol-4-yl}-6-(1,2,3,4-tetrahydroquinolin-7-yl)pyridine-2-carboxylate

tert-butyl 3-{1-[(3-{[13-(tert-butoxycarbonyl)-2,2,7,7-tetramethyl-10,10-dioxido-3,3-diphenyl-4,9-dioxa-10λ6-thia-13-aza-3-silapentadecan-15-yl]oxy}-5,7-dimethyltricyclo[3.3.1.13'7]dec-1-yl)methyl]-5-methyl-1H-pyrazol-4-yl}-6-(1,2,3,4-tetrahydroquinolin-7-yl)pyridine-2-carboxylate

[1,3]thiazolo[4,5-b]pyridin-2-amine
13575-41-2

[1,3]thiazolo[4,5-b]pyridin-2-amine

C74H96N8O10S2Si

C74H96N8O10S2Si

Conditions
ConditionsYield
Stage #1: di(succinimido) carbonate; [1,3]thiazolo[4,5-b]pyridin-2-amine In acetonitrile for 1h;
Stage #2: tert-butyl 3-{1-[(3-{[13-(tert-butoxycarbonyl)-2,2,7,7-tetramethyl-10,10-dioxido-3,3-diphenyl-4,9-dioxa-10λ6-thia-13-aza-3-silapentadecan-15-yl]oxy}-5,7-dimethyltricyclo[3.3.1.13'7]dec-1-yl)methyl]-5-methyl-1H-pyrazol-4-yl}-6-(1,2,3,4-tetrahydroquinolin-7-yl)pyridine-2-carboxylate In acetonitrile
Stage #1: di(succinimido) carbonate; [1,3]thiazolo[4,5-b]pyridin-2-amine In acetonitrile at 20℃; for 1h;
Stage #2: tert-butyl 3-{1-[(3-{[13-(tert-butoxycarbonyl)-2,2,7,7-tetramethyl-10,10-dioxido-3,3-diphenyl-4,9-dioxa-10λ6-thia-13-aza-3-silapentadecan-15-yl]oxy}-5,7-dimethyltricyclo[3.3.1.13'7]dec-1-yl)methyl]-5-methyl-1H-pyrazol-4-yl}-6-(1,2,3,4-tetrahydroquinolin-7-yl)pyridine-2-carboxylate In acetonitrile
7-[6-(tert-butoxycarbonyl)-5-{1-[(3-{[13-(tert-butoxycarbonyl)-2,2,7,7-tetramethyl-10,10-dioxido-3,3-diphenyl-4,9-dioxa-10 6-thia-13-aza-3-silapentadecan-15-yl]oxy}-5,7-dimethyltricyclo[3.3.1.13'7]dec-1-yl)methyl]-5-methyl-1H-pyrazol-4-yl}pyridin-2-yl]naphthalene-1-carboxylic acid

7-[6-(tert-butoxycarbonyl)-5-{1-[(3-{[13-(tert-butoxycarbonyl)-2,2,7,7-tetramethyl-10,10-dioxido-3,3-diphenyl-4,9-dioxa-10 6-thia-13-aza-3-silapentadecan-15-yl]oxy}-5,7-dimethyltricyclo[3.3.1.13'7]dec-1-yl)methyl]-5-methyl-1H-pyrazol-4-yl}pyridin-2-yl]naphthalene-1-carboxylic acid

[1,3]thiazolo[4,5-b]pyridin-2-amine
13575-41-2

[1,3]thiazolo[4,5-b]pyridin-2-amine

C75H93N7O10S2Si

C75H93N7O10S2Si

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane
di(succinimido) carbonate
74124-79-1

di(succinimido) carbonate

tert-butyl 3-{1-[(3-{[13-(tert-butoxycarbonyl)-2,2,7,7-tetramethyl-10,10-dioxido-3,3-diphenyl-4,9-dioxa-10λ6-thia-13-aza-3-silapentadecan-15-yl]oxy}-5,7-dimethyltricyclo[3.3.1.13'7]dec-1-yl)methyl]-5-methyl-1H-pyrazol-4-yl}-6-(1,2,3,4-tetrahydroquinolin-7-yl)pyridine-2-carboxylate

tert-butyl 3-{1-[(3-{[13-(tert-butoxycarbonyl)-2,2,7,7-tetramethyl-10,10-dioxido-3,3-diphenyl-4,9-dioxa-10λ6-thia-13-aza-3-silapentadecan-15-yl]oxy}-5,7-dimethyltricyclo[3.3.1.13'7]dec-1-yl)methyl]-5-methyl-1H-pyrazol-4-yl}-6-(1,2,3,4-tetrahydroquinolin-7-yl)pyridine-2-carboxylate

[1,3]thiazolo[4,5-b]pyridin-2-amine
13575-41-2

[1,3]thiazolo[4,5-b]pyridin-2-amine

3-{1-[(3,5-dimethyl-7-{2-[(2-sulfoethyl)amino]ethoxy}tricyclo[3.3.1.13'7]dec-1-yl)methyl]-5-methyl-1H-pyrazol-4-yl}-6-[1-([1,3]thiazolo[4,5-b]pyridin-2-ylcarbamoyl)-1,2,3,4-tetrahydroquinolin-7-yl]pyridine-2-carboxylic acid

3-{1-[(3,5-dimethyl-7-{2-[(2-sulfoethyl)amino]ethoxy}tricyclo[3.3.1.13'7]dec-1-yl)methyl]-5-methyl-1H-pyrazol-4-yl}-6-[1-([1,3]thiazolo[4,5-b]pyridin-2-ylcarbamoyl)-1,2,3,4-tetrahydroquinolin-7-yl]pyridine-2-carboxylic acid

Conditions
ConditionsYield
Stage #1: di(succinimido) carbonate; [1,3]thiazolo[4,5-b]pyridin-2-amine In acetonitrile for 1h;
Stage #2: tert-butyl 3-{1-[(3-{[13-(tert-butoxycarbonyl)-2,2,7,7-tetramethyl-10,10-dioxido-3,3-diphenyl-4,9-dioxa-10λ6-thia-13-aza-3-silapentadecan-15-yl]oxy}-5,7-dimethyltricyclo[3.3.1.13'7]dec-1-yl)methyl]-5-methyl-1H-pyrazol-4-yl}-6-(1,2,3,4-tetrahydroquinolin-7-yl)pyridine-2-carboxylate In acetonitrile
Stage #3: With trifluoroacetic acid
7-[6-(tert-butoxycarbonyl)-5-{1-[(3-{[13-(tert-butoxycarbonyl)-2,2,7,7-tetramethyl-10,10-dioxido-3,3-diphenyl-4,9-dioxa-10 6-thia-13-aza-3-silapentadecan-15-yl]oxy}-5,7-dimethyltricyclo[3.3.1.13'7]dec-1-yl)methyl]-5-methyl-1H-pyrazol-4-yl}pyridin-2-yl]naphthalene-1-carboxylic acid

7-[6-(tert-butoxycarbonyl)-5-{1-[(3-{[13-(tert-butoxycarbonyl)-2,2,7,7-tetramethyl-10,10-dioxido-3,3-diphenyl-4,9-dioxa-10 6-thia-13-aza-3-silapentadecan-15-yl]oxy}-5,7-dimethyltricyclo[3.3.1.13'7]dec-1-yl)methyl]-5-methyl-1H-pyrazol-4-yl}pyridin-2-yl]naphthalene-1-carboxylic acid

[1,3]thiazolo[4,5-b]pyridin-2-amine
13575-41-2

[1,3]thiazolo[4,5-b]pyridin-2-amine

3-{1-[(3,5-dimethyl-7-{2-[(2-sulfoethyl)amino]ethoxy}tricyclo[3.3.1.13'7]dec-1-yl)methyl]-5-methyl-1H-pyrazol-4-yl}-6-[8-([1,3]thiazolo[4,5-b]pyridin-2-ylcarbamoyl)naphthalen-2-yl]pyridine-2-carboxylic acid

3-{1-[(3,5-dimethyl-7-{2-[(2-sulfoethyl)amino]ethoxy}tricyclo[3.3.1.13'7]dec-1-yl)methyl]-5-methyl-1H-pyrazol-4-yl}-6-[8-([1,3]thiazolo[4,5-b]pyridin-2-ylcarbamoyl)naphthalen-2-yl]pyridine-2-carboxylic acid

Conditions
ConditionsYield
Stage #1: 7-[6-(tert-butoxycarbonyl)-5-{1-[(3-{[13-(tert-butoxycarbonyl)-2,2,7,7-tetramethyl-10,10-dioxido-3,3-diphenyl-4,9-dioxa-10 6-thia-13-aza-3-silapentadecan-15-yl]oxy}-5,7-dimethyltricyclo[3.3.1.13'7]dec-1-yl)methyl]-5-methyl-1H-pyrazol-4-yl}pyridin-2-yl]naphthalene-1-carboxylic acid; [1,3]thiazolo[4,5-b]pyridin-2-amine With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane
Stage #2: With trifluoroacetic acid In dichloromethane

13575-41-2Downstream Products

13575-41-2Relevant academic research and scientific papers

The synthesis and antimicrobial screening of some novel aza-imidoxy compounds as potential chemotherapeutic agents

Jain, Shilpi,Nagda, Devendra Prakash,Talesara

, p. 1665 - 1673 (2006)

Some novel azaimidoxy compounds viz. 2-{[(4-chlorophenyl)diazenyl]oxy}-1H -isoindole-1,3-(2H )-dione (Va), and 1-{[1-naphthyldiazenyl]oxy}pyrrolidine-2,5- dione (IVc), etc. have been synthesized by a simple diazotization reaction followed by a coupling with 2-hydroxy-1H -isoindole-1,3(2H )-dione (III)/1-hydroxypyrrolidine-2,5-dione (II) of corresponding aromatic primary amine derivatives at a suitable pH. A similar reaction with a [1,3]thiazolo[4,5- b ]pyridin-2-amine (VIII) lead us to some interesting results variable with a pH. The structure of all synthesized compounds has been established by IR, 1H NMR, and mass studies. These compounds have been screened for antimicrobial activities in order to evaluate the possibility of the derivatives to be used as potential chemotherapeutic agents. Copyright Taylor & Francis Group, LLC.

A thiazole pyridine compound and its preparation method

-

Paragraph 0027, (2017/05/23)

The invention relates to a thiazole pyridine compound and its preparation method. The compound is thiazolo(4,5-b)pyridine. The preparation method comprises the following steps: (1) a compound 13-bromine-2-aminopyridine is used as a starting material to react in the presence of benzoyl chloride and ammonium thiocyanate so as to obtain a benzoyl-protected thiourea-containing derivative compound 2; (2) the compound 2 undergoes hydrolysis to obtain a thiourea derivative compound; (3) the compound 3 undergoes ring closure under the action of NaH to generate a compound 4; and (4) the compound 4 undergoes deamination by the use of isoamyl nitrite to obtain a target product compound 5. According to the method, raw materials are cheap and easily available. The synthetic method is simple. The preparation method meets requirements of large-scale industrial production.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 13575-41-2